Products
Little Green Pharma — Australia's First Licensed Cannabis Producer (2026)
Little Green Pharma (ASX: LGP) was Australia's first TGA-licensed medicinal cannabis cultivator. A complete profile of LGP's products, cultivation operations, Australian patient access, and what sets this Perth-based company apart in 2026.
Little Green Pharma (LGP) holds a unique place in Australian cannabis history: it was the first company to receive a TGA cultivation and manufacture licence for medicinal cannabis in Australia. Founded in Perth in 2016 and listed on the ASX in January 2020, LGP has grown from a pioneering startup to one of Australia’s most established medicinal cannabis producers, with cultivation operations in both Western Australia and the Netherlands.
Company background and history
Founded: 2016, Perth, Western Australia
ASX listing: January 2020 (ASX: LGP)
Operational base: Perth, WA (Australia) and the Netherlands
Key achievement: First TGA-licensed medicinal cannabis cultivator in Australia
LGP was established by Dr. Paul MacLeman and Fleta Solomon during the period immediately following the federal government’s 2016 legislation enabling a commercial medicinal cannabis industry. The founders recognised that Australia’s regulatory framework would require pharmaceutical-grade domestic production, and positioned LGP to be first to market.
The company secured its TGA cultivation licence and began producing Australian-grown medicinal cannabis for the domestic market — a milestone that proved Australia could produce pharmaceutical-grade cannabis to international standards. In 2018, LGP also established operations in the Netherlands, giving it access to European cultivation expertise and the ability to import European-cultivated cannabis for the Australian market.
LGP’s cultivation operations
Australian cultivation (Perth, WA): LGP’s Perth facility is an indoor, controlled-environment cultivation operation. Key features:
- Pharmaceutical-grade growing environment with temperature, humidity and CO2 control
- LED lighting systems optimised for cannabinoid production
- Good Manufacturing Practice (GMP) standards
- Independent laboratory testing for cannabinoids, terpenes, pesticides, heavy metals and microbiological contaminants
- TGA cultivation and manufacture licences
Netherlands operations: LGP’s European operations provide additional cultivar diversity and production capacity. Dutch cannabis cultivation has decades of technical development, and LGP benefits from established European genetics and greenhouse expertise. European-cultivated LGP products are imported into Australia under TGA import licence.
Quality control: All LGP products undergo independent third-party testing before release. Certificates of Analysis (CoA) are available for each product batch and should be accessible through your prescribing pharmacist.
LGP product range
LGP produces a range of medicinal cannabis products across multiple formats and cannabinoid profiles. Key products available in Australia in 2026:
Dried flower (vaporisation):
- LGP Classic: Indica-dominant flower; moderate-to-high THC (typically 18–22%); earthy, piney terpene profile; suitable for evening pain and insomnia
- LGP Sativa: Sativa-dominant flower; moderate THC; uplifting terpene profile; suitable for daytime use
- LGP High CBD: High-CBD, low-THC flower for patients seeking CBD’s benefits without significant psychoactive effects
Cannabis oils:
- LGP Classic Oil: THC-dominant oil for pain and sleep; precise metered dosing
- LGP Medical Oil: Balanced THC:CBD formulations for broad-spectrum therapy
- LGP Avidekel-type: High-CBD oil inspired by the Israeli Avidekel cultivar; low THC; suitable for daytime anxiety and pain management without impairment
Capsules and other formats: LGP periodically expands its product range. Confirm current availability with your prescribing pharmacist.
LGP’s prescribing and access
LGP products are available through the standard TGA SAS-B prescription framework. You cannot purchase LGP products directly from the company — you need a valid prescription from a TGA-authorised prescriber.
How to access LGP products:
- Consult with a TGA-authorised prescriber (telehealth or in-person)
- Request or discuss LGP’s products — your prescriber can specify an LGP product in the TGA application
- Prescription is dispensed through a registered pharmacy that stocks LGP products
- Medicine is delivered to your address
Pharmacy availability: LGP products are widely stocked by major Australian cannabis pharmacy suppliers and dispensing services. Confirm specific product availability with your pharmacy.
What differentiates LGP
First-mover advantage: LGP’s 2016 founding and first licence mean it has more years of Australian cultivation data, compliance experience, and product development than almost any other Australian producer. This track record matters for product consistency.
Dual-country cultivation: Operating in both Australia and the Netherlands gives LGP genetic diversity and supply resilience. If Australian seasonal or regulatory factors affect production, European supply provides continuity.
Vertical integration (partial): LGP handles cultivation, extraction, and initial processing — providing more control over the supply chain than importers or repackagers.
TGA compliance record: As one of Australia’s longest-operating licensed producers, LGP’s compliance track record with the TGA is well-established.
LGP in the broader Australian market
LGP operates in a competitive market that has grown from a handful of licensed producers in 2017 to over 100 TGA-licensed entities in 2026. The company has maintained its position by focusing on pharmaceutical-grade production standards, product range expansion and building prescriber relationships.
For Australian patients, LGP products represent a known, established quality baseline — particularly appealing for patients and prescribers who value domestic production, supply chain transparency and a long compliance record.
Frequently asked questions — Little Green Pharma
Can I buy LGP products online without a prescription? No. LGP products are Schedule 8 (THC) or Schedule 4 (CBD) controlled substances in Australia. A valid TGA prescription from an authorised prescriber is required. LGP does not sell directly to consumers.
How do I know if my product is from LGP? Your prescription and pharmacy documentation will identify the specific product and manufacturer. LGP products are labelled with the company name and batch-specific Certificates of Analysis are available.
Are LGP products Australian-grown or imported? LGP has Australian-cultivated products (Perth facility) and imported European-cultivated products (Netherlands). Product packaging and Certificates of Analysis indicate origin. Both are produced to pharmaceutical-grade standards and TGA import requirements.
Is LGP publicly listed? Yes — LGP trades on the Australian Securities Exchange as ASX: LGP. As a listed company, it publishes regular financial reports and investor communications that provide transparency into its operations.
Are LGP products covered by Medicare or private health insurance? No — medicinal cannabis products including LGP products are not currently covered under the PBS for most conditions, and private health insurance does not cover cannabis prescriptions. Patients pay out-of-pocket.